98 related articles for article (PubMed ID: 15094386)
1. Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.
Sasaki K; Nakamura Y; Maki K; Waga K; Nakamura F; Arai H; Imai Y; Hirai H; Mitani K
Biochem Biophys Res Commun; 2004 May; 317(4):1128-37. PubMed ID: 15094386
[TBL] [Abstract][Full Text] [Related]
2. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
[TBL] [Abstract][Full Text] [Related]
3. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
[TBL] [Abstract][Full Text] [Related]
5. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
6. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
[TBL] [Abstract][Full Text] [Related]
8. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
9. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
Takahashi W; Sasaki K; Kvomatsu N; Mitani K
Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
[TBL] [Abstract][Full Text] [Related]
10. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
Jousset C; Carron C; Boureux A; Quang CT; Oury C; Dusanter-Fourt I; Charon M; Levin J; Bernard O; Ghysdael J
EMBO J; 1997 Jan; 16(1):69-82. PubMed ID: 9009269
[TBL] [Abstract][Full Text] [Related]
11. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.
Chakrabarti SR; Nucifora G
Biochem Biophys Res Commun; 1999 Nov; 264(3):871-7. PubMed ID: 10544023
[TBL] [Abstract][Full Text] [Related]
12. Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation.
Nguyen-Khac F; Della Valle V; Lopez RG; Ravet E; Mauchauffé M; Friedman AD; Huang LE; Fichelson S; Ghysdael J; Bernard OA
Oncogene; 2006 Aug; 25(35):4840-7. PubMed ID: 16547490
[TBL] [Abstract][Full Text] [Related]
13. TEL Induces Aggregation in Transformed Cells and Induces Tube Formation in NIH3T3-UCLA Cells.
Van Rompaey L; Holland E; Grosveld G
Biochem Biophys Res Commun; 2002 Mar; 291(4):820-8. PubMed ID: 11866439
[TBL] [Abstract][Full Text] [Related]
14. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
[TBL] [Abstract][Full Text] [Related]
15. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6).
Lopez RG; Carron C; Ghysdael J
J Biol Chem; 2003 Oct; 278(42):41316-25. PubMed ID: 12893822
[TBL] [Abstract][Full Text] [Related]
16. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor.
Wood LD; Irvin BJ; Nucifora G; Luce KS; Hiebert SW
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3257-62. PubMed ID: 12626745
[TBL] [Abstract][Full Text] [Related]
17. Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
Laitem C; Leprivier G; Choul-Li S; Begue A; Monte D; Larsimont D; Dumont P; Duterque-Coquillaud M; Aumercier M
Oncogene; 2009 May; 28(20):2087-99. PubMed ID: 19377509
[TBL] [Abstract][Full Text] [Related]
18. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
Dugast-Darzacq C; Pirity M; Blanck JK; Scherl A; Schreiber-Agus N
Oncogene; 2004 Nov; 23(55):8887-99. PubMed ID: 15467743
[TBL] [Abstract][Full Text] [Related]
19. Tel induces a G1 arrest and suppresses Ras-induced transformation.
Rompaey LV; Potter M; Adams C; Grosveld G
Oncogene; 2000 Nov; 19(46):5244-50. PubMed ID: 11077441
[TBL] [Abstract][Full Text] [Related]
20. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.
Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J
Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
